» Articles » PMID: 22098550

Liver Disease in Viet Nam: Screening, Surveillance, Management and Education: a 5-year Plan and Call to Action

Overview
Specialty Gastroenterology
Date 2011 Nov 22
PMID 22098550
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Despite a high prevalence of liver disease in Viet Nam, there has been no nationwide approach to the disease and no systematic screening of at-risk individuals. Risk factors include chronic hepatitis B (estimated prevalence of 12%), chronic hepatitis C (at least 2% prevalence), and heavy consumption of alcohol among men. This combination of factors has resulted in liver cancer being the most common cause of cancer death in Viet Nam. There is a general lack of understanding by both the general public and health-care providers about the major risk to health that liver disease represents. We report here the initial steps taken as part of a comprehensive approach to liver disease that will ultimately include nationwide education for health-care providers, health educators, and the public; expansion of nationwide screening for hepatitis B and C followed by hepatitis B virus vaccination or treatment of chronic hepatitis B and/or hepatitis C; education about alcoholic liver disease; long-term surveillance for liver cancer; reduction of infection transmission related to medical, commercial, and personal re-use of contaminated needles, syringes, sharp instruments, razors, and inadequately sterilized medical equipment; and ongoing collection and analysis of data about the prevalence of all forms of liver disease and the results of the expanded screening, vaccination, and treatment programs. We report the beginning results of our pilot hepatitis B screening program. We believe that this comprehensive nationwide approach could substantially reduce the morbidity and mortality from liver disease and greatly lessen the burden in terms of both lives lost and health-care costs.

Citing Articles

Prevalence of hepatitis coinfection and substance use among antiretroviral therapy clinic clients with hazardous alcohol use in Vietnam.

Chen J, Levintow S, Tran H, Sibley A, Blackburn N, Sripaipan T PLOS Glob Public Health. 2024; 4(12):e0003744.

PMID: 39636896 PMC: 11620398. DOI: 10.1371/journal.pgph.0003744.


Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Prospective Study.

Nguyen Thi Thu P, Ngo Thi Quynh M, Pham Van L, Nguyen Van H, Thanh H Biomed Res Int. 2022; 2022:6054677.

PMID: 35572735 PMC: 9106452. DOI: 10.1155/2022/6054677.


Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam.

Thanh Thi Le X, Ishizumi A, Nguyen H, Duong H, Dang H, Manh Do C Vaccine. 2020; 38(52):8343-8350.

PMID: 33221065 PMC: 10354407. DOI: 10.1016/j.vaccine.2020.11.009.


Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).

Rapoud D, Quillet C, Minh K, Hai V, Nguyen Thanh B, Tuyet T BMJ Open. 2020; 10(11):e039234.

PMID: 33208326 PMC: 7677340. DOI: 10.1136/bmjopen-2020-039234.


Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam.

The Due O, Thakkinstian A, Thavorncharoensap M, Sobhonslidsuk A, Wu O, Phuong N Value Health. 2020; 23(9):1180-1190.

PMID: 32940236 PMC: 7491253. DOI: 10.1016/j.jval.2020.03.018.